{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:55:54Z","timestamp":1761562554564},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can J Public Health"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1007\/bf03403970","type":"journal-article","created":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T20:47:01Z","timestamp":1568321221000},"page":"491-494","source":"Crossref","is-referenced-by-count":8,"title":["Methadone Use in Relation to Hepatitis C Virus Testing in British Columbia"],"prefix":"10.17269","volume":"101","author":[{"given":"Jane A.","family":"Buxton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margot E.","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Ramji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mel","family":"Krajden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,11,1]]},"reference":[{"issue":"6","key":"BF03403970_CR1","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1111\/j.1360-0443.2008.02188.x","volume":"103","author":"DM Novick","year":"2008","unstructured":"Novick DM, Kreek MJ. Critical issues in the treatment of hepatitis C virus infection in methadone maintenance patients. Addictiol. 2008;103(6):905\u201318.","journal-title":"Addictiol"},{"key":"BF03403970_CR2","volume-title":"The CHASE Project: Community Report #1","author":"British Columbia Centre for Excellence in HIV\/AIDS.","year":"2004","unstructured":"British Columbia Centre for Excellence in HIV\/AIDS. The CHASE Project: Community Report #1, 2004. Available at: http:\/\/www.chase.hivnet.ubc.ca \/pro-ject\/pubdocs\/chasedoc.htm (Accessed November 1, 2009)."},{"key":"BF03403970_CR3","volume-title":"Community Health and Safety Evaluation (CHASE) Project: Final Report","author":"British Columbia Centre for Excellence in HIV\/AIDS.","year":"2006","unstructured":"British Columbia Centre for Excellence in HIV\/AIDS. Community Health and Safety Evaluation (CHASE) Project: Final Report, 2006. Available at: http:\/\/www.chase.hivnet.ubc.ca \/project\/pubdocs\/chasedoc.htm (Accessed November 7, 2009)."},{"issue":"5","key":"BF03403970_CR4","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1097\/01.ede.0000135170.54913.9d","volume":"15","author":"H Hagan","year":"2004","unstructured":"Hagan H, Thiede H, Des Jarlais DC. Hepatitis C virus infection among injection drug users: Survival analysis of time to seroconversion. Epidemiol. 2004;15(5):543\u201349.","journal-title":"Epidemiol"},{"issue":"10","key":"BF03403970_CR5","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1093\/aje\/kwn237","volume":"168","author":"H Hagan","year":"2008","unstructured":"Hagan H, Pouget ER, Des Jarlais DC, Lelutiu-Weinberger C. Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: The influence of time and place. Am J Epidemio. 2008;168(10):1099\u2013109.","journal-title":"Am J Epidemio"},{"issue":"25","key":"BF03403970_CR6","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1056\/NEJM196906192802502","volume":"280","author":"VP Dole","year":"1969","unstructured":"Dole VP, Robinson JW, Orraca J, Towns E, Searcy P, Caine E. Methadone treatment of randomly selected criminal addicts. N Engl J Med. 1969;280(25):1372\u201393.","journal-title":"N Engl J Med"},{"key":"BF03403970_CR7","first-page":"1190","volume":"117","author":"I Sheerin","year":"2004","unstructured":"Sheerin I, Green T, Sellman D, Adamson S, Deering D. Reduction in crime by drug users on a methadone maintenance therapy program in New Zealand. N Z Med . 2004;117:1190\u201394.","journal-title":"N Z Med"},{"key":"BF03403970_CR8","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2105\/AJPH.77.2.169","volume":"77","author":"RE Chaisson","year":"1987","unstructured":"Chaisson RE, Moss AR, Onishi R, Osmond D, Carlson JR. Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco. Am J Public Health. 1987;77:169\u201372.","journal-title":"Am J Public Health"},{"issue":"4","key":"BF03403970_CR9","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jcv.2007.09.013","volume":"41","author":"KCK Lee","year":"2008","unstructured":"Lee KCK, Lim WWL, Lee SS. High prevalence of HCV in a cohort of injectors on methadone substitution treatment. J Clin Virol. 2008;41(4):297\u2013300.","journal-title":"J Clin Virol"},{"issue":"5&6","key":"BF03403970_CR10","first-page":"423","volume":"67","author":"H Hagan","year":"2000","unstructured":"Hagan H, Des Jarlais DC. HIV and HCV infection among injecting drug users. Mt Sinai J Med. 2000;67(5&6):423\u201328.","journal-title":"Mt Sinai J Med"},{"issue":"5&6","key":"BF03403970_CR11","first-page":"437","volume":"67","author":"DM Novick","year":"2000","unstructured":"Novick DM. The impact of hepatitis C virus infection on methadone maintenance treatment. Mt Sinai J Med. 2000;67(5&6):437\u201343.","journal-title":"Mt Sinai J Med"},{"issue":"9","key":"BF03403970_CR12","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1111\/j.1360-0443.2007.01912.x","volume":"102","author":"C Van Den Berg","year":"2007","unstructured":"Van Den Berg C, Smit C, Van Brussel G, Coutinho R, Prins M. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: Evidence from the Amsterdam Cohort Studies among drug users. Addiction. 2007;102(9):1454\u201362.","journal-title":"Addiction"},{"key":"BF03403970_CR13","volume-title":"PharmaCare\/PharmaNet Policies and Procedures Manual","author":"College of Pharmacists of British Columbia.","year":"2003","unstructured":"College of Pharmacists of British Columbia. PharmaCare\/PharmaNet Policies and Procedures Manual, 2003. Available at: http:\/\/www.bcpharmacists.org \/pharmanet\/resources\/general.php (Accessed January, 2010)."},{"key":"BF03403970_CR14","volume-title":"Data Access","author":"Population Data BC.","year":"2009","unstructured":"Population Data BC. Data Access, 2009. Available at: http:\/\/www.popdata.bc.ca \/dataaccess (Accessed January 10, 2010)."},{"key":"BF03403970_CR15","volume-title":"PharmaNet Data Disclosure","author":"College of Pharmacists of British Columbia.","year":"2007","unstructured":"College of Pharmacists of British Columbia. PharmaNet Data Disclosure, 2007. Available at: http:\/\/www.bcpharmacists.org \/library\/G-PharmaNet\/G-4_PharmaNet_Data_Disclosure\/5055-PNet_Data_Disclosure_Requests.pdf (Accessed January 10, 2010)."},{"issue":"2","key":"BF03403970_CR16","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/BF03405776","volume":"95","author":"JF Anderson","year":"2004","unstructured":"Anderson JF, Warren LD. Client retention in the British Columbia Methadone Program, 1996\u20131999. Can J Public Health. 2004;95(2):104\u20139.","journal-title":"Can J Public Health"},{"issue":"5&6","key":"BF03403970_CR17","first-page":"347","volume":"67","author":"H Joseph","year":"2000","unstructured":"Joseph H, Stancliff S, Langrod J. Methadone Maintenance Treatment (MMT): A review of historical and clinical issues. Mt Sinai J Med. 2000;67(5&6):347\u201364.","journal-title":"Mt Sinai J Med"},{"issue":"6","key":"BF03403970_CR18","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1093\/aje\/kwp186","volume":"170","author":"B Nosyk","year":"2009","unstructured":"Nosyk B, MacNab YC, Sun H, Fischer B, Marsh DC, Schechter MT, et al. Proportional hazards frailty models for recurrent methadone maintenance treatment. Am J Epidemiol. 2009;170(6):783\u201392.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"BF03403970_CR19","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0740-5472(93)90104-A","volume":"10","author":"F Lehmann","year":"1993","unstructured":"Lehmann F, Lauzon P, Amsel R. Methadone maintenance: Predictors of outcome in a Canadian milieu. J Substance Abuse Treatment. 1993;10(1):85\u201389.","journal-title":"J Substance Abuse Treatment"},{"issue":"1","key":"BF03403970_CR20","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/00005721-200401000-00010","volume":"29","author":"MA Taylor-Seehafer","year":"2004","unstructured":"Taylor-Seehafer MA. Positive youth development: Reducing the health risks of homeless youth. Am J Maternal Child Nursing. 2004;29(1):36\u201340.","journal-title":"Am J Maternal Child Nursing"},{"issue":"7","key":"BF03403970_CR21","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1086\/342063","volume":"35","author":"DC Ompad","year":"2002","unstructured":"Ompad DC, Fuller CM, Vlahov D, Thomas D, Strathdee SA. Lack of behavior change after disclosure of hepatitis C virus infection among young injection drug users in Baltimore, Maryland. Clin Infect Dis. 2002;35(7):783\u201388.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"BF03403970_CR22","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1046\/j.1360-0443.2002.00208.x","volume":"97","author":"CF Kwiatkowski","year":"2002","unstructured":"Kwiatkowski CF, Fortuin Corsi K, Booth RE. The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users. Addictiol. 2002;97(10):1289\u201394.","journal-title":"Addictiol"},{"issue":"7","key":"BF03403970_CR23","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1046\/j.1360-0443.2001.967100710.x","volume":"96","author":"M McCusker","year":"2001","unstructured":"McCusker M. Influence of hepatitis C status on alcohol consumption in opiate users in treatment. Addiction. 2001;96(7):1007\u201314.","journal-title":"Addiction"},{"issue":"2","key":"BF03403970_CR24","first-page":"750","volume":"36","author":"E Wood","year":"2004","unstructured":"Wood E, Spittal P, Li K, Kerr T, Miller CL, Hogg RS, et al. Inability to access addiction treatment and risk of HIV infection among injection drug users. JAID. 2004;36(2):750\u201354.","journal-title":"JAID"},{"key":"BF03403970_CR25","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/1471-2458-10-225","volume":"10","author":"J Buxton","year":"2010","unstructured":"Buxton J, Yu A, Alvarez M, Kuo M, Krajden M, Gilbert M, et al. HCV co-infection in HIV positive population in British Columbia. BMC Public Health. 2010;10:225.","journal-title":"BMC Public Health"},{"key":"BF03403970_CR26","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1365-2893.2006.00820.x","volume":"14","author":"G Jayaraman","year":"2007","unstructured":"Jayaraman G, Lee B, Singh A, Preiksaitis J. Trends in testing behaviours for hepatitis C virus infection and associated determinants: Results from population-based laboratory surveillance in Alberta, Canada (1998\u20132001). J Viral Hep. 2007;14:249\u201354.","journal-title":"J Viral Hep"},{"issue":"2","key":"BF03403970_CR27","first-page":"743","volume":"36","author":"CL Miller","year":"2004","unstructured":"Miller CL, Wood E, Spittal PM, Li K, Frankish JC, Braitstein P, et al. The future face of coinfection - Prevalence and incidence of HIV and hepatitis C virus coinfection among young injection drug users. JAID. 2004;36(2):743\u201349.","journal-title":"JAID"},{"issue":"3","key":"BF03403970_CR28","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3402\/ijch.v66i3.18259","volume":"66","author":"PM Spittal","year":"2007","unstructured":"Spittal PM, Craib KJP, Teegee M, Baylis C, Christian WM, Moniruzzaman AKM, et al. The Cedar Project: Prevalence and correlates of HIV infection among young Aboriginal people who use drugs in two Canadian cities. Int J Circumpolar Health. 2007;66(3):226\u201340.","journal-title":"Int J Circumpolar Health"}],"container-title":["Canadian Journal of Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03403970.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03403970\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03403970.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,7]],"date-time":"2019-12-07T04:24:54Z","timestamp":1575692694000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03403970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["BF03403970"],"URL":"https:\/\/doi.org\/10.1007\/bf03403970","relation":{},"ISSN":["0008-4263","1920-7476"],"issn-type":[{"value":"0008-4263","type":"print"},{"value":"1920-7476","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}